Selection of breast carcinoma patients for endocrine therapy
Sannella, J.J.
Journal of the Tennessee Medical Association 68(12): 982
1975
ISSN/ISBN: 0040-3318 PMID: 1207129 Document Number: 94540
Document emailed within 1 workday
Related Documents
Cikes, M.; Pettavel, J. 1977: Selection of patients with breast cancer with regard to endocrine therapy Schweizerische Medizinische Wochenschrift 107(46): 1645-1655Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Shimazaki, J.; Fuse, H.; Ohshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K.; Saito, Y. 1991: Clinical studies on endocrine therapy for prostatic carcinoma (4): Initial response to endocrine therapy and prognosis Hinyokika Kiyo. Acta Urologica Japonica 37(11): 1505-1510
Howell, A.; Harland, R.N.; Barnes, D.M.; Baildam, A.D.; Wilkinson, M.J.; Hayward, E.; Swindell, R.; Sellwood, R.A. 1987: Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment Cancer Research 47(1): 300-304
2011: Categorization of triple-negative breast cancer patients will help in targeted therapy selection Oncology 25(9): 849
Geyer, G. 1980: New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma Wiener Medizinische Wochenschrift 130(15-16): 501-509
Nesković-Konstantinović, Z.; Filipović, S. 2003: The role of endocrine therapy in early breast cancer: adjuvant treatment of preand postmenopausal patients Journal of Buon: Official Journal of the Balkan Union of Oncology 8(1): 11-17
Nomura, Y.; Yamagata, J.; Kondo, H.; Takenaka, K. 1978: Endocrine adjuvant therapy with the antiestrogen, mepitiostane, inoperable breast cancer patients on the basis of estrogen receptor assay Gan 69(2): 281-282
Meiss, L.; Djandji, V.; Raute, M.; Kühn, W. 1974: Therapy of breast carcinoma. Surgical, radiologic and hormonal treatment of a patient with breast carcinoma metastases. Clinical course with regard to pre-terminal immunoglobulin and complement changes Fortschritte der Medizin 92(14): 615-616
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Cleton, F.J.; Engelsman, E.; Nooy, M. 1986: Adjuvant therapy in patients with operable breast carcinoma Nederlands Tijdschrift Voor Geneeskunde 130(16): 719-721
Nohara, T.; Iwamoto, M.; Kobayashi, T.; Lee, S.-W.; Sumiyoshi, K.; Tanigawa, N. 2003: Examination of therapy using trastuzumab in patients with metastatic breast carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(11): 1651-1654
Holder, W.D.; Wells, S.A. 1983: Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma: a possible serological detection method for breast carcinoma Cancer Research 43(1): 239-244
Jonat, W.; Maass, H. 1987: Endocrine therapy of breast cancer Zentralblatt für Gynakologie 109(10): 617-627
Yoshida, M.; Miura, S. 1984: Internal endocrine therapy of breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(5): 989-998
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Taguchi, T. 1998: Adjuvant for breast cancer chemo-endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 453-467
Jakesz, R.; Hausmaninger, H. 1984: Adjuvant endocrine forms of therapy in breast cancer Wiener Klinische Wochenschrift 96(13): 492-499
Mustacchi, G.; Milani, S.; Pluchinotta, A.; De Matteis, A.; Rubagotti, A.; Perrota, A. 1994: Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: the G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly Anticancer Research 14(5b): 2197-2200
Morrow, M. 1998: Age as a selection factor for the local therapy of breast cancer? Journal of the American College of Surgeons 187(1): 94-95
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Harada, M.; Shimazaki, J.; Fuse, H.; Oshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K. 1990: Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis Hinyokika Kiyo. Acta Urologica Japonica 36(3): 295-305